Additionally, considering BRD4 linkage to MYC has been demonstrated in multiple disease settings, we examined the anti-tumor activity of AZD5153 in a MYC amplified (but also with BRD4 copy-number gain of 3) ovarian patient-derived xenograft, OV0452F. This evidence concerns the gene BRD4 and neoplasm.